Breast cancer and microRNAs: Therapeutic impact

Breast

Volumn 20, Issue SUPPL. 3, 2011, Pages

  Iorio, Marilena V ^a   Casalini, Patrizia ^a   Piovan, Claudia ^a,b   Braccioli, Luca ^a   Tagliabue, Elda ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Human breast cancer; MicroRNAs

Indexed keywords

ESTROGEN RECEPTOR; FULVESTRANT; GEMCITABINE; LET 7 MIRNA; LETROZOLE; LOCKED NUCLEIC ACID; MESSENGER RNA; MICRORNA; MICRORNA 10B; MICRORNA 141; MICRORNA 155; MICRORNA 15A; MICRORNA 16 1; MICRORNA 191; MICRORNA 21; MICRORNA 222; MICRORNA 26; MICRORNA 34A; MIRAVIRSEN; PLACEBO; SHORT HAIRPIN RNA; TAMOXIFEN; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; BREAST CANCER; BREAST CARCINOMA; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RESISTANCE; CANCER STAGING; CHROMOSOME 13Q; CHROMOSOME 13Q14; CHROMOSOME DELETION 13; CHROMOSOME DELETION 13Q14; CHRONIC LYMPHATIC LEUKEMIA; DRUG DOSE ESCALATION; GENE EXPRESSION PROFILING; GENE MAPPING; HUMAN; LYMPH NODE METASTASIS; MOLECULARLY TARGETED THERAPY; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROGNOSIS; TUMOR GROWTH; TUMOR MICROENVIRONMENT; TUMOR SUPPRESSOR GENE;

EID: 80054875021     PISSN: 09609776     EISSN: 15323080     Source Type: Journal    
DOI: 10.1016/S0960-9776(11)70297-1     Document Type: Article

References (85)

1. Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W, Tuschl T Identification of tissue-specific microRNAs from mouse. Curr Biol 2002 Apr30, 12:735-739.
2. Bartel DP MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004 Jan 23, 116:281-297.
3. Croce CM, Calin GA miRNAs, cancer, and stem cell division. Cell 2005 Jul 15, 122:6-7.
4. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res 2005 Aug 15, 65:7065-7070.
5. Iorio MV, Croce CM microRNAs in cancer: small molecules with a huge impact. J Clin Oncol 2009, 27:5848-5856.
6. Lee RC, Feinbaum RL, Ambros V The C. elegans heterochronic gene Iin-4 encodes small RNAs with antisense complementarity to Iin-14. Cell 1993 Dec 3, 75(5):843-854.
7. Kim VN MicroRNA biogenesis: coordinated cropping and dicing. Nat Rev Mol Cell Biol 2005 May, 6(5):376-385.
8. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13ql4 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 2002 Nov 26, 99:15524-15529.
9. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 2004 Mar 2, 101:2999-3004.
10. Calin GA, Croce CM MicroRNA signatures in human cancers. Nat Rev Cancer 2006 Nov, 6(ll):857-866.
11. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad SciUSA 2008 Jul 29, 105(30):10513-10518.
12. Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007 Jun, 9(6):654-659.
13. Lawrie CH, Gal S, Dunlop HM, Pushkaran B, Liggins AP, Pulford K, et al. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. BrJ Haematol 2008 May, 141(5):672-675.
14. Boeri M, Verri C, Conte D, Roz L, Modena P, Facchinetti F, et al. MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer. Proc Natl Acad Sci U S A 2011 Mar l, 108(9):3713-3718.
15. Roth C, Rack B, Muller V, Janni W, Pantel K, Schwarzenbach H Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer. Breast Cancer Res 2010, 12(6):R90.
16. Heneghan HM, Miller N, Kerin MJ Circulating miRNA signatures: promising prognostic tools for cancer. J Clin Oncol 2010 Oct 10, 28(29):e573-e574.
17. Zhao H, Shen J, Medico L, Wang D, Ambrosone CB, Liu S A pilot study of circulating miRNAs as potential biomarkers of early stage breast cancer. PLoS ONE 2010 Oct 29, 5(10):el3735.
18. Yan LX, Huang XF, Shao Q, Huang MY, Deng L, Wu QL, et al. MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA 2008 Nov, 14:2348-2360.
19. Ojan B, Katsaros D, Lu L, Preti M, Durando A, Arisio R, et al. High miR-21 expression in breast cancer associated with poor disease-free survival in early stage disease and high TGF-betal. Breast Cancer Res Treat 2008 Oct.
20. Walter BA, Gomez-Macias G, Valera VA, Sobel M, Merino MJ miR-21 Expression in Pregnancy-Associated Breast Cancer: A Possible Marker of Poor Prognosis. J Cancer 2011 Feb 7, 2:67-75.
21. Asaga S, Kuo C, Nguyen T, Terpenning M, Giuliano AE, Hoon DS Direct serum assay for microRNA-21 concentrations in early and advanced breast cancer. Clin Chem 2011 Jan, 57(l):84-91.
22. Wang F, Zheng Z, Guo J, Ding X Correlation and quantitation of microRNA aberrant expression in tissues and sera from patients with breast tumor. Gynecol Oncol 2010 Dec, 119(3):586-593.
23. Taylor DD, Gercel-Taylor C MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol 2008 Jul, 110(l):13-21.
24. Ota D, Mimori K, Yokobori T, Iwatsuki M, Kataoka A, Masuda N, et al. Identification of recurrence-related microRNAs in the bone marrow of breast cancer patients. IntJ Oncol 2011 Apr, 38(4):955-962.
25. Chan JA, Krichevsky AM, Kosik KS MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 2005 Jul 15, 65:6029-6033.
26. Ciafre SA, Galardi S, Mangiola A, Ferracin M, Liu CG, Sabatino G, et al. Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem Biophys Res Commun 2005 Sep 9, 334:1351-1358.
27. Iorio MV, Visone R, Di LG, Donati V, Petrocca F, Casalini P, et al. MicroRNA signatures in human ovarian cancer. Cancer Res 2007 Sep 15, 67:8699-8707.
28. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M, et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 2006 Mar, 9(3):189-198.
29. Markou A, Tsaroucha EG, Kaklamanis L, Fotinou M, Georgoulias V, Lianidou ES Prognostic value of mature microRNA-21 and microRNA-205 overexpression in non-small cell lung cancer by quantitative real-time RT-PCR. Clin Chem 2008 Oct, 54:1696-1704.
30. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad SciUSA 2006 Feb 14, 103(7):2257-2261.
31. Schetter AJ, Leung SY, Sohn JJ, Zanetti KA, Bowman ED, Yanaihara N, et al. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAVM 2008 Jan 30, 299:425-436.
32. Roldo C, Missiaglia E, Hagan JP, Falconi M, Capelli P, Bersani S, et al. MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. J Clin Oncol 2006 Oct 10, 24:4677-4684.
33. Bloomston M, Frankel WL, Petrocca F, Volinia S, Alder H, Hagan JP, et al. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA 2007 May 2, 297:1901-1908.
34. Meister G, Landthaler M, Dorsett Y, Tuschl T Sequence-specific inhibition of microRNA- and siRNA-induced RNA silencing. RNA 2004 Mar, 10(3):544-550.
35. Hutvagner G, Simard MJ, Mello CC, Zamore PD Sequence-specific inhibition of small RNA function. PLoS Biol 2004 Apr, 2(4):E98.
36. Yu F, Yao H, Zhu P, Zhang X, Pan Q, Gong C, et al. let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 2007 Dec 14, 131:1109-1123.
37. Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng A, et al. RAS is regulated by the let-7 microRNA family. Cell 2005 Mar ll, 120(5):635-647.
38. Mayr C, Hemann MT, Bartel DP Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science 2007 Mar 16, 315:1576-1579.
39. Sampson VB, Rong NH, Han J, Yang Q, Aris V, Soteropoulos P, et al. MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells. Cancer Res 2007 Oct 15, 67:9762-9770.
40. Kumar MS, Erkeland SJ, Pester RE, Chen CY, Ebert MS, Sharp PA, et al. Suppression of non-small cell lung tumor development by the let-7 microRNA family. Proc Natl Acad Sci USA 2008 Mar 11, 105:3903-3908.
41. Adams BD, Furneaux H, White BA The micro-ribonucleic acid (miRNA) miR-206 targets the human estrogen receptor-alpha (ERalpha) and represses ERalpha messenger RNA and protein expression in breast cancer cell lines. Mol Endocrinol 2007 May, 21(5):1132-1147.
42. Foekens JA, Sieuwerts AM, Smid M, Look MP, de VW, et al. Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer. Proc Natl Acad Sci USA 2008 Sep 2, 105:13021-13026.
43. Masri S, Liu Z, Phung S, Wang E, Yuan YC, Chen S The role of microRNA-128a in regulating TGFbeta signaling in letrozole-resistant breast cancer cells. Breast Cancer Res Treat 2010 Nov, 124(l):89-99.
44. Di Leva G, Gasparini G, Piovan C, Ngankeu A, Garofalo M, Taccioli C, et al. A regulatory "miRcircuitry" involving miR-221&222 and ERalpha determines ERalpha status of breast cancer cells. J Natl Cancer Inst 2010, 102:706-721.
45. Zhao JJ, Lin J, Yang H, Kong W, He L, Ma X, et al. MicroRNA-221/222 negatively regulates estrogen receptor alpha and is associated with tamoxifen resistance in breast cancer. J BioZ. Chem 2008 Nov 7, 283(45):31079-31086.
46. Miller TE, Ghoshal K, Ramaswamy B, Roy S, Datta J, Shapiro CL, et al. MicroRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p27Kipl. JBiol Chem 2008 Oct 31, 283:29897-29903.
47. Rao X, Di LG, Li M, Fang F, Devlin C, Hartman-Frey C, et al. MicroRNA-221/222 confers breast cancer fulvestrant resistance by regulating multiple signaling pathways. Oncogene 2011 Mar 3, 30(9):1082-1097.
48. Tavazoie SF, Alarcon C, Oskarsson T, Padua D, Wang Q, Bos PD, et al. Endogenous human microRNAs that suppress breast cancer metastasis. Nature 2008 Jan 10, 451:147-152.
49. Ma L, Teruya-Feldstein J, Weinberg RA Tumour invasion and metastasis initiated by microRNA-lOb in breast cancer. Nature 2007 Oct 11, 449:682-688.
50. Png KJ, Yoshida M, Zhang XH, Shu W, Lee H, Rimner A, et al. MicroRNA-335 inhibits tumor reinitiation and is silenced through genetic and epigenetic mechanisms in human breast cancer. Genes Dev 2011 Feb 1, 25(3):226-231.
51. Fish JE, Santoro MM, Morton SU, Yu S, Yeh RF, Wythe JD, et al. miR-126 regulates angiogenic signaling and vascular integrity. Dev Cell 2008 Aug, 15:272-284.
52. Wang S, Aurora AB, Johnson BA, Qi X, McAnally J, Hill JA, et al. The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev Cell 2008 Aug, 15(2):261-271.
53. Dews M, Homayouni A, Yu D, Murphy D, Sevignani C, Wentzel E, et al. Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster. Nat Genet 2006 Sep, 38(9):1060-1065.
54. Suarez Y, Fernandez-Hernando C, Yu J, Gerber SA, Harrison KD, Pober JS, et al. Dicer-dependent endothelial microRNAs are necessary for postnatal angiogenesis. Proc Natl Acad Sci USA 2008 Sep 16, 105:14082-14087.
55. Camps C, Buffa FM, Colella S, Moore J, Sotiriou C, Sheldon H, et al. hsa-miR-210 Is induced by hypoxia and is an independent prognostic factor in breast cancer. Clin Cancer Res 2008 Mar 1, 14:1340-1348.
56. Iorio MV, Casalini P, Piovan C, Di Leva G, Merlo A, Triulzi T, et al. microRNA-205 regulates HER3 in human breast cancer. Cancer Res 2009 Mar 15, 69:2195-2200.
57. Wu H, Zhu S, Mo YY Suppression of cell growth and invasion by miR-205 in breast cancer. Cell Res 2009 Feb 24, 19:439-448.
58. Gregory PA, Bracken CR, Bert AG, Goodall GJ MicroRNAs as regulators of epithelial-mesenchymal transition. Cell Cycle 2008 Oct, 7(20):3112-3118.
59. Radojicic J, Zaravinos A, Vrekoussis T, Kafousi M, Spandidos DA, Stathopoulos EN MicroRNA expression analysis in triple-negative (ER, PR and Her2/neu) breast cancer. Cell Cycle 2011 Feb 1, 10(3):507-517.
60. Calin GA, Cimmino A, Fabbri M, Ferracin M, Wojcik SE, Shimizu M, et al. MiR-15a and miR-16-1 cluster functions in human leukemia. Proc Natl Acad Sci USA 2008 Apr 1, 105:5166-5171.
61. Si ML, Zhu S, Wu H, Lu Z, Wu F, Mo YY miR-21-mediated tumor growth. Oncogene 2007 Apr 26, 26:2799-2803.
62. Meng F, Henson R, Lang M, Wehbe H, Maheshwari S, Mendell JT, et al. Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Gastroenterology 2006 Jun, 130:2113-2129.
63. Xia L, Zhang D, Du R, Pan Y, Zhao L, Sun S, et al. miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells. IntJ Cancer 2008 Jul 15, 123(2):372-379.
64. Weidhaas JB, Babar I, Nallur SM, Trang P, Roush S, Boehm M, et al. MicroRNAs as potential agents to alter resistance to cytotoxic anticancer therapy. Cancer Res 2007 Dec 1, 67:11111-11116.
65. Tazawa H, Tsuchiya N, Izumiya M, Nakagama H Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells. Proc Natl Acad Sci U S A 2007 Sep 25, 104(39):15472-15477.
66. Chen Y, Zhu X, Zhang X, Liu B, Huang L Nanoparticles modified with tumor-targeting scFv deliver siRNA and miRNA for cancer therapy. Mol Ther 2010 Sep, 18(9):1650-1656.
67. Esquela-Kerscher A, Trang P, Wiggins JF, Patrawala L, Cheng A, Ford L, et al. The let-7 microRNA reduces tumor growth in mouse models of lung cancer. Cell Cycle 2008 Mar 15, 7(6):759-764.
68. Kota J, Chivukula RR, O'Donnell KA, Wentzel EA, Montgomery CL, Hwang HW, et al. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 2009 Jun 12, 137(6):1005-1017.
69. Chang TC, Yu D, Lee YS, Wentzel EA, Arking DE, West KM, et al. Widespread microRNA repression by Myc contributes to tumorigenesis. Nat Genet 2008 Jan, 40(l):43-50.
70. Care A, Catalucci D, Felicetti F, Bonci D, Addario A, Gallo P, et al. MicroRNA-133 controls cardiac hypertrophy. Nat Med 2007 May, 13(5):613-618.
71. Tiscornia G, Singer O, Ikawa M, erma IM A general method for gene knockdown in mice by using lentiviral vectors expressing small interfering RNA. Proc Natl Acad Sci U S A 2003 Feb 18, 100(4):1844-1848.
72. Xia H, Mao Q, Eliason SL, Harper SQ, Martins IH, Orr HT, et al. RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia. Nat Med 2004 Aug, 10(8):816-820.
73. Kawasaki H, Taira K Short hairpin type of dsRNAs that are controlled by tRNA(Val) promoter significantly induce RNAi-mediated gene silencing in the cytoplasm of human cells. Nucleic Acids Res 2003 Jan 15, 31(2):700-707.
74. Grimm D, Streetz KL, Jopling CL, Storm TA, Pandey K, Davis CR, et al. Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways. Nature 2006 May 25, 441(7092):537-541.
75. Lee Y, Kim M, Han J, Yeom KH, Lee S, Baek SH, et al. MicroRNA genes are transcribed by RNA polymerase II. EMBOJ 2004 Oct 13, 23(20):4051-4060.
76. Weiler J, Hunziker J, Hall J Anti-miRNA oligonucleotides (AMOs): ammunition to target miRNAs implicated in human disease?. Gene Ther 2006 Mar, 13:496-502.
77. Esau C, Davis S, Murray SF, Yu XX, Pandey SK, Pear M, et al. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab 2006 Feb, 3(2):87-98.
78. Krutzfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, Manoharan M, et al. Silencing of microRNAs in vivo with 'antagomirs'. Nature 2005 Dec l, 438:685-689.
79. Ma L, Reinhardt F, Pan E, Soutschek J, Bhat B, Marcusson EG, et al. Therapeutic silencing of miR-lOb inhibits metastasis in a mouse mammary tumor model. Nat Biotechnol 2010 Apr, 28(4):341-347.
80. Orom UA, Kauppinen S, Lund AH LNA-modified oligonucleotides mediate specific inhibition of microRNA function. Gene 2006 May 10, 372:137-141.
81. Elmen J, Lindow M, Silahtaroglu A, Bak M, Christensen M, Lind-Thomsen A, et al. Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver. Nucleic Adds Res 2008 Mar, 36:1153-1162.
82. Elmen J, Lindow M, Schutz S, Lawrence M, Petri A, Obad S, et al. LNA-mediated microRNA silencing in non-human primates. Nature 2008 Apr 17, 452:896-899.
83. Ebert MS, Neilson JR, Sharp PA MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat Methods 2007 Sep, 4:721-726.
84. Gentner B, Schira G, Giustacchini A, Amendola M, Brown BD, Ponzoni M, et al. Stable knockdown of microRNA in vivo by lentiviral vectors. Nat Methods 2009 Jan, 6:63-66.
85. Su J, Baigude H, McCarroll J, Rana TM Silencing microRNA by interfering nanoparticles in mice. Nucleic Adds Res 2011 Jan 6.